Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE2
GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE1
Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
- Status
- TERMINATED
- Phase
- N/A
Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis
- Status
- UNKNOWN
- Phase
- PHASE1
TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3435151 in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Anlotinib After Lenvatinib in Patients With Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers
- Status
- TERMINATED
- Phase
- NA
Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- N/A
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)
- Status
- UNKNOWN
- Phase
- PHASE3
The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
- Status
- UNKNOWN
- Phase
- PHASE3